1. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 french endoscopy centers
- Author
-
G Boulay, J A Seyrig, J Dubuc, D. Sautereau, Jean-Yves Scoazec, J Butel, M Winnock, T. Barrioz, Thierry Ponchon, J P Barbier, D Grasset, D Grigoresco, R. Laugier, Jean-Louis Legoux, and Société Française d'Endoscopie Digestive
- Subjects
Adult ,Male ,medicine.medical_specialty ,Esophageal Neoplasms ,Sensitivity and Specificity ,Gastroenterology ,Risk Factors ,Internal medicine ,Biopsy ,medicine ,Carcinoma ,Humans ,Esophagus ,Coloring Agents ,Prospective cohort study ,Aged ,Aged, 80 and over ,Staining and Labeling ,medicine.diagnostic_test ,business.industry ,Biopsy, Needle ,Cancer ,Iodides ,Middle Aged ,medicine.disease ,Endoscopy ,medicine.anatomical_structure ,Dysplasia ,Carcinoma, Squamous Cell ,Pancreatitis ,Female ,Esophagoscopy ,business ,Precancerous Conditions - Abstract
BACKGROUND AND STUDY AIMS The prevalence of esophageal squamous-cell carcinoma in high-risk patients and the advantages of systematic Lugol staining during esophagoscopy have not yet been evaluated in a large prospective study. In this study we aimed to assess the prevalence of this type of tumor in high-risk patients, to examine the role of Lugol staining in endoscopic screening for esophageal squamous-cell carcinoma, and to establish whether it is possible to identify a particularly high-risk group which would benefit from systematic screening. PATIENTS AND METHODS A prospective study was undertaken in 62 endoscopy centers. A total of 1095 patients were enrolled, none of whom had any esophageal symptoms. These patients had presented with either a past history of or a recent head and neck or tracheobronchial squamous-cell carcinoma (group 1), with alcoholic chronic pancreatitis (group 2), with alcoholic cirrhosis (group 3), or were alcohol and tobacco addicts (group 4). The patients underwent a meticulous endoscopic examination of the esophagus, followed by Lugol staining. RESULTS The prevalence of esophageal squamous-cell carcinoma was 3.2 %. The group 1 patients showed the highest prevalence of carcinoma (5.3 %) and the highest prevalence of dysplasia (4.5 %). Of the 35 carcinomas detected in the 1095 patients, seven (20 %) were early lesions, and 20 % were only detected after Lugol staining (P = 0.02). High-grade dysplasia was only observed in group 1 patients and two-thirds of these lesions were only diagnosed after Lugol staining. The overall prevalence of low-grade dysplasia was 2.4 %, and 77 % of these were detected only after Lugol staining (P < 0.001). CONCLUSIONS Lugol dye staining increases the sensitivity of esophageal endoscopy for the detection of high-grade dysplasia and cancer. The prevalence of dysplasia and cancer reached 9.9 % in group 1, and we therefore believe that an endoscopic screening program could be justified for patients with head and neck or tracheobronchial cancer.
- Published
- 2006
- Full Text
- View/download PDF